Losartan Potassium Tablets — Class II drug recall D-1162-2022
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2022-07-06, distributed nationwide. CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
| Recall number | D-1162-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2022-06-06 |
| Classified | 2022-06-27 |
| Reported by FDA | 2022-07-06 |
| Terminated | 2024-06-17 |
| Distributed | Nationwide (US) |
| Quantity | 687 bottles |
| Reason classes | cgmp, specification failure |
| UPC / GTIN / UDI-DI | 00372789164908 |
| NDC | 72789-0163, 72789-0163-90, 72789-0164, 72789-0164-90, 72789-0165, 72789-0165-90 |
| Lot numbers | D21D63, E21A73, E21D35, F21A28, F21D04, G21B03, G21E23, H21B46, H21D46, I21B67, J21A26, J21C44 |
| Expiration dates | 2022-09-30, 2022-11-30, 2023-01-31, 2023-08-31 |
Product
Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc. Oklahoma City, OK 73127 Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108 SIDCO Pharmaceutical Complex, Alathur, Kanchipuram-603 110, Tamilnadu, India NDC 72789-164-90 UPC 3 72789 16490 8
Reason for recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1162-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.